English
Sandu Pharmaceuticals Q2 Results
- BSE: 524703
- NSE: -
- ISIN: INE751D01014
- Sector: Biotechnology & Drugs
BSE
38.01
-1.48 (-3.75%)
-1.48 (-3.75%)Volume1.77 K
Updated: Tue 9 Dec, 2025 | 14:50:31
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹17.62 Cr.(-0.47%)
- Operating Profit₹0.69 Cr.(-5.88%)
- Profit After Tax₹0.52 Cr.(5.83%)
- Operating Margin3.93%(-5.43%)
Note: Comparison is on YoY basis
Quarterly - Sandu Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 16.93 | 16.35 | 3.52% | 16.97 | -0.24% |
| Depreciation/ Amortization | 0.17 | 0.18 | -5.01% | 0.17 | -3.10% |
| Operating Income | 0.69 | 0.35 | 99.54% | 0.74 | -5.88% |
| Net Income | 0.52 | 0.22 | 134.75% | 0.50 | 5.83% |
| Other Operating Expenses Total | 5.79 | 4.68 | 23.88% | 6.03 | -3.85% |
| Net Income Before Taxes | 0.71 | 0.34 | 110.95% | 0.74 | -3.05% |
| Total Revenue | 17.62 | 16.70 | 5.52% | 17.70 | -0.47% |
| Selling/ General/ Admin Expenses Total | 2.64 | 2.66 | -0.96% | 2.61 | 1.16% |
| Diluted Normalized EPS | 0.54 | 0.23 | 134.78% | 1.95 | -72.31% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.